Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.

Damato V. et al, (2022), J Neurol Neurosurg Psychiatry, 93, 995 - 1000

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

Cetin H. et al, (2020), J Neurol Neurosurg Psychiatry

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.

Huda S. et al, (2020), Neurol Neuroimmunol Neuroinflamm, 7

Myasthenia gravis

Gilhus NE. et al, (2019), Nature Reviews Disease Primers, 5

Antiglycine receptor antibody related disease: a case series and literature review.

Swayne A. et al, (2018), Eur J Neurol, 25, 1290 - 1298

NMDA-receptor antibodies alter cortical microcircuit dynamics.

Rosch RE. et al, (2018), Proceedings of the National Academy of Sciences of the United States of America, 115, E9916 - E9925

Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes

Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137

A passive transfer animal model of CASPR2 antibodies

Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674

Load More